Prostate artery embolisation (2022 – CME) – online course
Authors: A. Kovács and P. Bischoff
Reviewers: V. Bérczi, G. Makris, C. Nice, M. Tsitskari and F. Wolf
This course corresponds to chapter 126.96.36.199 Prostate Artery Embolisation (PAE) and 188.8.131.52 Non-Vascular Interventional Oncology in the European Curriculum and Syllabus for IR.
Benign prostatic hyperplasia is a common disease, mostly of the elderly man, occurring in over 50% of men aged 60 years and older. After an asymptomatic period, many men consult a urologist due to lower urinary tract symptoms (LUTS), which include, amongst others, incomplete bladder emptying, nocturia, frequent urination, intermittency and infections.
Prostatic arterial embolisation is an effective and safe endovascular procedure that decreases the prostatic size, mainly by induced infarction of the median prostatic lobe. In contrast to surgical treatments, patients don’t face operative risks and side effects such as erectile dysfunction, retrograde ejaculation and incontinence.
- Become acquainted with patient selection according to procedure indications
- Get familiar with the materials and how to choose them correctly
- Understand the pelvic vascular anatomy
- Learn about possible origins of the prostatic artery and anatomic norm variants
- Achieve technical skills to plan and perform the intervention
- Learn about complication management
- Learn about post-procedural management and follow-up
This course covers a basic level of IR knowledge and is designed for trainees, students or young consultants aiming to acquire essential knowledge or prepare for the EBIR exam. Thereby, it is tailored to the European Curriculum and Syllabus for IR and corresponds to chapter 184.108.40.206 Prostate Artery Embolisation (PAE) and 220.127.116.11 Non-Vascular Interventional Oncology.
The format of the course is interactive and easy to use, including texts, graphics, videos and a quiz to support your learning. The course duration is around two hours and is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to award 2 European CME credits (ECMEC). The CME accreditation for this course will expire on October 17, 2024. A non-CME accredited version of the course will remain available for two more years.
The enrolment period of this course is set to 90 days and may be extended throughout the year with a valid Digital All-Access Pass.
The CME Certificate will be available in the myCIRSE area past the enrolment period if the course is completed before October 17, 2024.
Release date: October 2022